Spinraza's Cost Effectiveness Exceeds Swedish Willingness to Pay Threshold & Being a Writer With SMA - a podcast by SMA News Today

We discuss how the cost effectiveness of Spinraza exceeds Swedish willingness to pay threshold. Also, Community Editor Kevin Schaefer reads from one of his forum posts, in which he shares advice about being a freelance writer with SMA.

Are you interested in understanding gene therapy? ExploreGeneTherapy.com has helpful information about gene therapy, including its history and how it is being investigated for the treatment of genetic diseases. Visit www.exploregenetherapy.com
====================================

Further episodes of SMA News & Perspectives

Further podcasts by SMA News Today

Website of SMA News Today